Read: AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design AION Labs, Powered by BioMed X, Launches First Global Call for Application: Artificial Intelligence for Antibody Design Oct 19, 2021
Read: AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders AION Labs, Biotech Innovation Lab Launched by Top Pharma, Tech and Investment Leaders Oct 13, 2021
Read: BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen BioMed X Institute today announces two new research groups in autoimmunity and drug delivery in collaboration with Janssen Aug 2, 2021
Read: BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology Jul 5, 2021
Read: BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity BioMed X Institute and Merck Extend Collaboration to Continue Novel Research in Oncology and Autoimmunity May 17, 2021
Read: BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim BioMed X Institute launches new global call in neuroscience in collaboration with Boehringer Ingelheim Mar 29, 2021
Read: BioMed X Institute starts new research project in drug delivery in collaboration with Janssen BioMed X Institute starts new research project in drug delivery in collaboration with Janssen Jan 26, 2021
Read: BioMed X Institute completes first research project in neuroscience with Boehringer Ingelheim BioMed X Institute completes first research project in neuroscience with Boehringer Ingelheim Dec 8, 2020
Read: BioMed X Institute announces expansion of their strategic collaboration with Janssen in immunology research BioMed X Institute announces expansion of their strategic collaboration with Janssen in immunology research Nov 9, 2020
Read: BioMed X Institute launches Rapid Antiviral Response Platform to prevent future pandemics BioMed X Institute launches Rapid Antiviral Response Platform to prevent future pandemics May 13, 2020
Read: BioMed X starts new schizophrenia research program with Boehringer Ingelheim BioMed X starts new schizophrenia research program with Boehringer Ingelheim Jan 13, 2020
Read: BioMed X starts new research program in autoimmune diseases with Merck BioMed X starts new research program in autoimmune diseases with Merck Jan 9, 2020
Read: BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases BioMed X and Boehringer Ingelheim to investigate early intervention in psychiatric diseases Jan 17, 2019
Read: BioMed X and Merck extend research collaboration in oncology BioMed X and Merck extend research collaboration in oncology May 8, 2018
Read: BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity BioMed X and Boehringer Ingelheim start new joint research group in bacterial modulation of innate immunity Nov 27, 2017
Read: BioMed X Announces Biomedical Research Collaboration with Janssen BioMed X Announces Biomedical Research Collaboration with Janssen Oct 25, 2017
Read: BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing Jun 8, 2017
Read: BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity BioMed X and Boehringer Ingelheim launch new crowdsourcing project to identify key regulatory mechanisms in innate immunity Feb 6, 2017
Read: BioMed X and Merck start new project in cancer research BioMed X and Merck start new project in cancer research Nov 3, 2016
Read: BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation BioMed X announces the start of new research team on Oral Biofilm Disruption through continued collaboration with Johnson & Johnson Innovation Sep 6, 2016
Read: Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing Boehringer Ingelheim and BioMed X start new project to explore and develop unprecedented new treatment approaches for psychiatric diseases applying crowdsourcing May 23, 2016
In the Media In the Media Media is constantly reporting on BioMed X Institute and its work. Read our current media coverage. Read more
Our Events Our Events Interested to learn more about our innovation model and our research projects? Check out our list of events. Read more